Renoprotective Effect of Febuxostat Compared with Allopurinol in Hyperuricemic Chronic Kidney Disease Patients Stage 3 and 4 | ||
| Medicine Updates | ||
| Article 8, Volume 9, Issue 9, April 2022, Pages 71-105 PDF (1.37 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/muj.2022.115662.1086 | ||
| Authors | ||
| Heba Selim Elshair1; Yasser Ahmed Nienaa1; Rana Ibrahim Koreen1; Noha M Elkholy* 2 | ||
| 1Faculty of medicine Alexandria University internal medicine department | ||
| 2Department of internal medicine faculty of medicine Alexandria University | ||
| Abstract | ||
| Abstract Background: Chronic kidney disease is a heterogeneous group of disorders involving changes in kidney structure and function. For many decades they thought that hyperuricemia causes impairment to renal function through retention of uric acid caused by impaired renal excretion. Allopurinol has been the mainstay therapy for gout and hyperuricemia associated conditions for a long time. Allopurinol has a rare but serious hypersensitivity reaction CKD patients are at higher risk of this complication. Febuxostat drug is a new potent agent which seems to be tolerable in patients involving those who develop Allopurinol sensitivity. It is a non- purine compound; It selectively inhibit xanthine oxidoreductase enzyme Aim: To assess the renoprotective effect of Febuxostat in comparison with Allopurinol in hyperuricemic CKD patients stage 3 and 4. Material and methods: This retrospective study included 300 patients selected from Renal outpatient clinic at Alexandria Main University Hospital and private clinics. • 150 patients CKD stage (3,4) with hyperuricemia treated with Febuxostat renal modified dose. • 150 patients CKD stage (3,4) with hyperuricemia treated with Allopurinol renal modified dose. Results: In Febuxostat group than Allopurinol group at 6 months (u=8644.5, p=0.001) and 12 months (u=6316.0, p <0.001). At 6 months and 12 months data revealed no significant difference in eGFR slopes between the Febuxostat and Allopurinol groups Keywords: Chronic Kidney Disease, Hyperuricemia, Allopurinol, Febuxostat. | ||
| Keywords | ||
| Chronic Kidney Disease; Hyperuricemia; Allopurinol; Febuxostat | ||
|
Statistics Article View: 329 PDF Download: 370 |
||
